Previous 10 | Next 10 |
deCODE genetics: A sequence variant that increases risk of pregnancy loss Canada NewsWire REYKJAVIK, Iceland , Jan. 29, 2024 /CNW/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland , Denmark, and the USA ...
2024-01-28 12:00:53 ET More on Amgen, Vertex Pharma, etc. Biotech And Pharma Diversification Pays Off Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar...
2024-01-28 11:07:33 ET Summary SCHD is a crowd favorite dividend ETF. How does it fare against us Seeking Alpha active dividend investors? A review of why active dividend investors have more opportunities than passive investors. Written by Sam Kovacs Introduc...
2024-01-27 09:00:00 ET Cancer bites, but Amgen (NASDAQ: AMGN) is going to keep biting back. In fact, it's currently developing a handful of oncology medicines that it describes as bispecific T-cell engager therapies, or BiTEs for short. As a relatively new therapeutic modality, ...
2024-01-26 14:10:51 ET Summary Low-cost ETFs are advantageous for long-term wealth accumulation due to low expense ratios, diversification, and flexibility. SCHG and SCHD are both some of the best low-cost ETFs in the market today. We compare them side-by-side and offer our pe...
2024-01-26 07:16:34 ET More on Cigna, CVS Health, etc. Humana: The $300 Level Could Get Taken Out In The Near Future Humana Inc. (HUM) Q4 2023 Earnings Call Transcript CVS Health: Back In The Buy Column Humana gets downgrade at Deutsche Bank as stock nears fo...
2024-01-22 16:18:02 ET Summary Amgen's stock price has surged, driven by strategic acquisitions, a diverse medical portfolio, and a focus on AI innovation, positioning it for substantial long-term growth. Amgen's strong performance stems from its diverse presence in general medici...
2024-01-19 11:52:40 ET The U.S. Food and Drug Administration has issued a boxed warning on the prescribing information for Amgen's ( NASDAQ: AMGN ) osteoporosis drug, Prolia (denosumab), Reuters reported on Friday. Boxed warnings are the most serious warnings issued by the U...
2024-01-19 08:00:00 ET Summary The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks c...
2024-01-18 09:12:34 ET Summary Shares of Tourmaline Bio, Inc. have surged 200% since its public debut in October 2023. The company's main asset, TOUR006, shows potential as a therapy for thyroid eye disease and atherosclerotic cardiovascular disease. Tourmaline is conducting P...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...